| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13792* | 2021 |
| A simple method for clinical assay of superoxide dismutase. YI Sun, LW Oberley, Y Li Clinical chemistry 34 (3), 497-500, 1988 | 5540 | 1988 |
| Free radicals, antioxidant enzymes, and carcinogenesis Y Sun Free Radical Biology and Medicine 8 (6), 583-599, 1990 | 1590 | 1990 |
| Redox regulation of transcriptional activators YI Sun, LW Oberley Free Radical Biology and Medicine 21 (3), 335-348, 1996 | 933 | 1996 |
| Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ... Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008 | 841 | 2008 |
| PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway M Tan, Y Wang, K Guan, Y Sun Proceedings of the National Academy of Sciences 97 (1), 109-114, 2000 | 405 | 2000 |
| p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389 C Huang, WY Ma, A Maxiner, Y Sun, Z Dong Journal of Biological Chemistry 274 (18), 12229-12235, 1999 | 373 | 1999 |
| Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter J Bian, YI Sun Molecular and cellular biology 17 (11), 6330-6338, 1997 | 361 | 1997 |
| The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells H Qin, Y Sun, EN Benveniste Journal of Biological Chemistry 274 (41), 29130-29137, 1999 | 359 | 1999 |
| Targeting p53 for novel anticancer therapy Z Wang, Y Sun Translational oncology 3 (1), 1-12, 2010 | 358 | 2010 |
| DEPTOR, an mTOR inhibitor, is a physiological substrate of SCFβTrCP E3 ubiquitin ligase and regulates survival and autophagy Y Zhao, X Xiong, Y Sun Molecular cell 44 (2), 304-316, 2011 | 323 | 2011 |
| Transcriptional activation of the human glutathione peroxidase promoter by p53 M Tan, S Li, M Swaroop, K Guan, LW Oberley, Y Sun Journal of Biological Chemistry 274 (17), 12061-12066, 1999 | 307 | 1999 |
| p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107 PP Claudio, CM Howard, A Baldi, A De Luca, Y Fu, G Condorelli, Y Sun, ... Cancer research 54 (21), 5556-5560, 1994 | 305 | 1994 |
| Cullin-RING Ligases as attractive anti-cancer targets Y Zhao, Y Sun Current pharmaceutical design 19 (18), 3215-3225, 2013 | 298 | 2013 |
| Radiosensitization of p53 Mutant Cells by PD0166285, a Novel G2 Checkpoint Abrogator Y Wang, J Li, RN Booher, A Kraker, T Lawrence, WR Leopold, Y Sun Cancer research 61 (22), 8211-8217, 2001 | 269 | 2001 |
| E3 ubiquitin ligases as cancer targets and biomarkers Y Sun Neoplasia 8 (8), 645-654, 2006 | 258 | 2006 |
| The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth Z Luo, G Yu, HW Lee, L Li, L Wang, D Yang, Y Pan, C Ding, J Qian, L Wu, ... Cancer research 72 (13), 3360-3371, 2012 | 255 | 2012 |
| SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP J Lu, L Bai, H Sun, Z Nikolovska-Coleska, D McEachern, S Qiu, RS Miller, ... Cancer research 68 (22), 9384-9393, 2008 | 248 | 2008 |
| TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells MR Smith, H Kung, SK Durum, NH Colburn, Y Sun Cytokine 9 (10), 770-780, 1997 | 237 | 1997 |
| Targeting E3 ubiquitin ligases for cancer therapy Y Sun Cancer biology & therapy 2 (6), 623-629, 2003 | 219 | 2003 |
Zhao YongchaoZhejiang University School of MedicineEmail verificata su zju.edu.cn